The Role of Circular RNA for Early Diagnosis and Improved Management of Patients with Cardiovascular Diseases

Int J Mol Sci. 2024 Mar 4;25(5):2986. doi: 10.3390/ijms25052986.

Abstract

Cardiovascular diseases (CVDs) are responsible for approximately 17.9 million deaths every year. There is growing evidence that circular RNAs (circRNAs) may play a significant role in the early diagnosis and treatment of cardiovascular diseases. As regulatory molecules, circular RNAs regulate gene expression, interact with proteins and miRNAs, and are translated into proteins that play a key role in a wide variety of biological processes, including the division and proliferation of cells, as well as the growth and development of individuals. An overview of the properties, expression profiles, classification, and functions of circRNAs is presented here, along with an explanation of their implications in cardiovascular diseases including heart failure, hypertension, ischemia/reperfusion injury, myocardial infarction, cardiomyopathies, atherosclerosis, and arrhythmia.

Keywords: biological processes; cardiovascular disease; circRNA; regulatory molecules.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases* / metabolism
  • Early Diagnosis
  • Humans
  • MicroRNAs* / genetics
  • Proteins
  • RNA / metabolism
  • RNA, Circular / genetics

Substances

  • RNA, Circular
  • MicroRNAs
  • Proteins
  • RNA

Grants and funding

This research was made possible through the support and funding provided by the University of Medicine and Pharmacy Victor Babes Timisoara, Romania.